Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study.
Ryota OzawaKei SoneharaTsutomu HachiyaShuhei NozawaToshihiko AgatsumaHiroshi YamamotoAkane KatoAkemi MatsuoTaro HirabayashiTaisuke ArakiMasamichi KomatsuKazunari TateishiMasayuki HanaokaPublished in: Cancer medicine (2024)
The study results suggest that high serum Alb is a predictive factor for irAE development and that the presence of multiple irAEs is a favorable prognostic indicator for NSCLC patients undergoing chemoimmunotherapy.